tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MRNS Stock Latest News

Marinus Pharmaceuticals Faces Financial Turmoil Amidst Class Action Lawsuit
Company AnnouncementsMarinus Pharmaceuticals Faces Financial Turmoil Amidst Class Action Lawsuit
1M ago
MRNS
Marinus Pharmaceuticals Reports Q3 Growth in ZTALMY Revenue
PremiumCompany Announcements
Marinus Pharmaceuticals Reports Q3 Growth in ZTALMY Revenue
1M ago
MRNS
Marinus Pharmaceuticals reports Q3 EPS (42c), consensus (41c)
PremiumThe Fly
Marinus Pharmaceuticals reports Q3 EPS (42c), consensus (41c)
1M ago
MRNS
Is MRNS a Buy, Before Earnings?
PremiumPre-Earnings
Is MRNS a Buy, Before Earnings?
2M ago
MRNS
Marinus Pharmaceuticals price target lowered to $1 from $3 at RBC Capital
PremiumThe Fly
Marinus Pharmaceuticals price target lowered to $1 from $3 at RBC Capital
2M ago
MRNS
Marinus Pharmaceuticals price target lowered to $4 from $13 at Cantor Fitzgerald
PremiumThe FlyMarinus Pharmaceuticals price target lowered to $4 from $13 at Cantor Fitzgerald
2M ago
MRNS
Marinus Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Marinus Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
2M ago
MRNS
Marinus Pharmaceuticals downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Marinus Pharmaceuticals downgraded to Hold from Buy at TD Cowen
2M ago
MRNS
Marinus Pharmaceuticals downgraded to Hold from Buy at Jefferies
PremiumThe Fly
Marinus Pharmaceuticals downgraded to Hold from Buy at Jefferies
2M ago
MRNS
Marinus Pharmaceuticals price target lowered to $3 from $23 at EF Hutton
PremiumThe Fly
Marinus Pharmaceuticals price target lowered to $3 from $23 at EF Hutton
2M ago
MRNS
Marinus Pharmaceuticals price target lowered to 50c from $2 at Baird
PremiumThe Fly
Marinus Pharmaceuticals price target lowered to 50c from $2 at Baird
2M ago
MRNS
Marinus Pharmaceuticals downgraded to Market Perform at JMP Securities
PremiumThe Fly
Marinus Pharmaceuticals downgraded to Market Perform at JMP Securities
2M ago
MRNS
Marinus downgraded to Market Perform from Outperform at JMP Securities
PremiumThe FlyMarinus downgraded to Market Perform from Outperform at JMP Securities
2M ago
MRNS
Marinus Pharmaceuticals downgraded to Hold from Buy at Truist
Premium
The Fly
Marinus Pharmaceuticals downgraded to Hold from Buy at Truist
2M ago
MRNS
Marinus notes TrustTSC trial misses primary endpoint, to evaluate alternatives
Premium
The Fly
Marinus notes TrustTSC trial misses primary endpoint, to evaluate alternatives
2M ago
MRNS
Marinus Pharmaceuticals presents clinical data from pivotal phase 3 RAISE trial
PremiumThe Fly
Marinus Pharmaceuticals presents clinical data from pivotal phase 3 RAISE trial
2M ago
MRNS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
WVE
BHVN
Microsoft downgraded, Pinterest initiated: Wall Street’s top analyst calls
PremiumThe Fly
Microsoft downgraded, Pinterest initiated: Wall Street’s top analyst calls
3M ago
BK
GM
Marinus Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
PremiumThe Fly
Marinus Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
3M ago
MRNS
Marinus Pharmaceuticals provides Ztalmy program update at investor day
PremiumThe FlyMarinus Pharmaceuticals provides Ztalmy program update at investor day
3M ago
MRNS
Truist healthcare analyst holds an analyst/industry conference call
Premium
The Fly
Truist healthcare analyst holds an analyst/industry conference call
4M ago
JAZZ
LBPH
Ladenburg downgrades Marinus on balance sheet concerns
Premium
The Fly
Ladenburg downgrades Marinus on balance sheet concerns
4M ago
MRNS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >